ESR1 and breast cancer: We next examined whether stromal cells may be able to modulate signal pathway activities and protein expression also in other ERα-positive breast cancer cell lines (BT474 and T47D) in a similar way as in MCF-7 cells and whether they may also affect cell growth in the presence of fulvestrant.